Overall rank by patents
#3,402
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Neuravi Limited
USPTO PatentsView assignee record - 109 granted patents across 7 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
109
Total patents granted
7
CPC technology areas
16.3
Avg claims per patent
+274%
5-year filing velocity
The verdict
Neuravi holds 109 US patents across 7 technology areas, rank #3,402 of 50,000 tracked assignees.
- #3,402
- of 50,000 US assignees by volume
- Top 15%
- by Innovation Score (49.3/100)
- 16.3
- avg claims per patent
- +274%
- filing velocity, last 5 yrs
Portfolio overview
Neuravi Limited has been granted 109 US utility patents between 2016 and 2025, placing Neuravi Limited at rank #3,402 across all assignees tracked by PlainPatent. This portfolio spans 7 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.3 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Neuravi Limited is one of the more focused assignees in the PatentsView dataset. By volume, Neuravi sits between I.m.a. Industria Macchine Automatiche S.p.a. (109 patents, rank #3,398) and Shanghai Institute OF Materia Medica, Chinese Academy OF Sciences (109 patents, rank #3,406) - the closest US assignees by grant volume. The composite Innovation Score of 49.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 86 grants, compared with 23 in the 2015–2019 window, a +274% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Neuravi Limited's 16.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 7 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Neuravi Limited against peers pursuing similar technology classes.
Who files at Neuravi's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- I M A Industria M…
I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A.
109 patents
- Ionq
IonQ, Inc.
109 patents
- Kerr Machine
Kerr Machine Co.
109 patents
- Mr Bar-b-q Produc…
Mr. Bar-B-Q Products LLC
109 patents
- Nucor
Nucor Corporation
109 patents
- Progressive Inter…
Progressive International Corp.
109 patents
- Rittal & KG
RITTAL GMBH & CO. KG
109 patents
- Shanghai Institut…
SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
109 patents
- Neuravi ◀
NEURAVI LIMITED
109 patents
What this shows Neuravi holds 109 patents at rank #3,402, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Neuravi
By rank, the assignees closest to #3,402 in granted patent volume.
- I.m.a. Industria Macchine Automatiche S.p.a. #3,398 · 109 patents
- Ionq, Inc. #3,399 · 109 patents
- Kerr Machine Co. #3,400 · 109 patents
- Mr. Bar-b-q Products Llc #3,401 · 109 patents
- Nucor Corporation #3,403 · 109 patents
- Progressive International Corp. #3,404 · 109 patents
- Rittal Gmbh & Co. KG #3,405 · 109 patents
- Shanghai Institute OF Materia Medica, Chinese Academy OF Sciences #3,406 · 109 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Neuravi's primary technology class.
- Covidien Lp 5,709 in class
- Koniniklijke Philips N.v. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag Gmbh International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- Depuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Neuravi's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
49 Top 15% higher than 85% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 6 | 5.5% |
| 2017 | 2 | 1.8% |
| 2018 | 2 | 1.8% |
| 2019 | 13 | 11.9% |
| 2020 | 12 | 11.0% |
| 2021 | 5 | 4.6% |
| 2022 | 16 | 14.7% |
| 2023 | 15 | 13.8% |
| 2024 | 32 | 29.4% |
| 2025 | 6 | 5.5% |
Which technologies does Neuravi Limited patent most?
Top 7 of 7 technology areas
Patent Moat Analysis
Portfolio Volume Moderate
Tech Breadth Focused
Claim Depth Standard
Velocity Accelerating
Frequently Asked Questions
How many patents does Neuravi Limited hold?
Neuravi Limited holds 109 US granted patents filed between 2016 and 2025, spanning 7 technology areas.
What is Neuravi Limited's Innovation Score?
Neuravi Limited has an Innovation Score of 49.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Neuravi Limited focus on?
Neuravi Limited's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 106 patents. The company has filed patents in 7 CPC subclasses total.
Is Neuravi Limited's patent filing rate increasing or decreasing?
Neuravi Limited's recent filing velocity is +274% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Neuravi Limited's patents?
Neuravi Limited's patents average 16.3 claims each. This falls within the standard range, providing solid legal coverage.
How is the Neuravi Limited patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Neuravi's 109 grants land it in the top 15% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Neuravi ranks #3,402 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.